A.M. Thompson

733 total citations
24 papers, 552 citations indexed

About

A.M. Thompson is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, A.M. Thompson has authored 24 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in A.M. Thompson's work include Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer-related Molecular Pathways (4 papers). A.M. Thompson is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer-related Molecular Pathways (4 papers). A.M. Thompson collaborates with scholars based in United Kingdom, United States and Italy. A.M. Thompson's co-authors include Boikanyo Makubate, Peter T. Donnan, Colin McCowan, J A Dewar, Tracey Rapson, Fiona J. Gilbert, M. Virginia C. L. Appleyard, Kermit K. Murray, Philip J. Coates and Y. Liu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

A.M. Thompson

22 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Thompson United Kingdom 11 223 136 123 110 98 24 552
Jennifer Westrup United States 7 268 1.2× 171 1.3× 177 1.4× 97 0.9× 32 0.3× 12 562
M. Ziller Germany 12 317 1.4× 115 0.8× 70 0.6× 57 0.5× 31 0.3× 26 586
Aviva G. Asnis-Alibozek United States 5 170 0.8× 158 1.2× 117 1.0× 131 1.2× 23 0.2× 7 489
Àngels Arcusa Spain 16 616 2.8× 49 0.4× 234 1.9× 302 2.7× 156 1.6× 34 1.0k
Seraina Schmid Switzerland 16 342 1.5× 55 0.4× 419 3.4× 119 1.1× 153 1.6× 48 972
Reuben Broom New Zealand 14 445 2.0× 27 0.2× 242 2.0× 271 2.5× 168 1.7× 35 780
Kunal C. Kadakia United States 13 208 0.9× 20 0.1× 45 0.4× 90 0.8× 93 0.9× 43 455
Kara Laing Canada 12 274 1.2× 15 0.1× 138 1.1× 114 1.0× 35 0.4× 26 537
Naresh Bellam United States 7 161 0.7× 51 0.4× 53 0.4× 26 0.2× 17 0.2× 12 457
David Yao United States 13 107 0.5× 79 0.6× 22 0.2× 126 1.1× 143 1.5× 25 686

Countries citing papers authored by A.M. Thompson

Since Specialization
Citations

This map shows the geographic impact of A.M. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Thompson more than expected).

Fields of papers citing papers by A.M. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Thompson. The network helps show where A.M. Thompson may publish in the future.

Co-authorship network of co-authors of A.M. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Thompson. A scholar is included among the top collaborators of A.M. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Thompson. A.M. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Robinson, Thomas E., Neil Eisenstein, Sophie C. Cox, et al.. (2020). Local injection of a hexametaphosphate formulation reduces heterotopic ossification in vivo. Materials Today Bio. 7. 100059–100059. 11 indexed citations
3.
Liu, Y., Rudolf Nenutil, M. Virginia C. L. Appleyard, et al.. (2014). Lack of correlation of stem cell markers in breast cancer stem cells. British Journal of Cancer. 110(8). 2063–2071. 82 indexed citations
4.
Kirwan, Cliona, Wail Al Sarakbi, J. Loncaster, et al.. (2013). Tumour bed clip localisation for targeted breast radiotherapy: Compliance is proportional to trial-related research activity. European Journal of Surgical Oncology. 40(2). 158–162. 9 indexed citations
5.
Makubate, Boikanyo, Peter T. Donnan, J A Dewar, A.M. Thompson, & Colin McCowan. (2013). Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. British Journal of Cancer. 108(7). 1515–1524. 231 indexed citations
6.
Palmieri, Carlo, Martino Monteverde, Laura Lattanzio, et al.. (2012). Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse. British Journal of Cancer. 107(4). 732–738. 12 indexed citations
7.
Ribi, Karin, Julie Aldridge, Kelly‐Anne Phillips, et al.. (2012). Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British Journal of Cancer. 106(10). 1618–1625. 17 indexed citations
8.
Shimi, S. M., et al.. (2012). Improved short term surgical outcomes in Scotland for oesophageal cancer. European Journal of Surgical Oncology. 39(2). 131–135. 4 indexed citations
9.
Suttie, Stuart, et al.. (2011). The impact of operative approach for oesophageal cancer on outcome: The transhiatal approach may influence circumferential margin involvement. European Journal of Surgical Oncology. 38(2). 157–165. 13 indexed citations
10.
Ribi, Karin, Julie Aldridge, Kelly‐Anne Phillips, et al.. (2010). Changes in cognitive function in postmenopausal women 1 year after completing adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial.. Journal of Clinical Oncology. 28(15_suppl). 527–527. 1 indexed citations
11.
Amaral, Teresa, S.J. McKenna, Katherine Robertson, & A.M. Thompson. (2009). Automated classification of breast tissue microarray spots.. Cancer Research. 69(2_Supplement). 4010–4010. 2 indexed citations
12.
Liu, Huiping, A.M. Thompson, & Kay F. Macleod. (2005). A novel form of pRb expressed during normal myelopoiesis and in tumour‐associated macrophages. Cell Proliferation. 38(1). 13–24. 3 indexed citations
13.
Rapson, Tracey, et al.. (2005). Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy – data from the Scottish audit of gastric and oesophageal cancer. Alimentary Pharmacology & Therapeutics. 23(2). 229–233. 9 indexed citations
15.
Thompson, A.M., et al.. (2002). Risk factors for post-stem cell transplant sinusitis. Bone Marrow Transplantation. 29(3). 257–261. 29 indexed citations
16.
Thompson, A.M., et al.. (2002). Upper GI 11. British journal of surgery. 89(S1). 26–27. 1 indexed citations
17.
Hislop, Robert, Norman Pratt, S. Craig Stocks, et al.. (2002). Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. British journal of surgery. 89(12). 1581–1586. 26 indexed citations
18.
Warbrick, Emma, David A. Johnston, John Dillon, et al.. (2001). The p53 functional yeast assay predicts radiation sensitivity in gastro-oesophageal cell lines. Discovery Research Portal (University of Dundee). 1 indexed citations
19.
Hupp, Ted R., et al.. (2001). Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring. British Journal of Cancer. 85(8). 1102–1105. 7 indexed citations
20.
Hupp, Ted R., et al.. (2000). p53 and breast cancer. The Breast. 9(5). 239–246. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026